Literature DB >> 18482003

Complexity of COX-2 gene regulation.

Kelly A Harper1, Alison J Tyson-Capper.   

Abstract

Overexpression of the enzyme COX-2 (cyclo-oxygenase-2) is associated with various pathophysiological conditions, including inflammatory diseases and different cancers. Increased synthesis of COX-2 in fetal membranes and the myometrium is also linked with the onset of term and preterm labour. COX-2 gene regulation is controlled at various levels including gene transcription and post-transcriptional events. The present article focuses on the complexity of COX-2 gene regulation and reviews current concepts that highlight: (i) transcription of COX-2 is induced rapidly and transiently in response to a plethora of stimuli; (ii) COX-2 mRNA stability and translational efficiency is governed by multiple regulatory elements within the 3'-untranslated region; (iii) specific microRNAs and RNA-binding proteins influence COX-2 mRNA stability; and (iv) regulation of COX-2 involves alternative polyadenylation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18482003     DOI: 10.1042/BST0360543

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  44 in total

1.  Coordinated post-transcriptional regulation of Hsp70.3 gene expression by microRNA and alternative polyadenylation.

Authors:  Michael Tranter; Robert N Helsley; Waltke R Paulding; Michael McGuinness; Cole Brokamp; Lauren Haar; Yong Liu; Xiaoping Ren; W Keith Jones
Journal:  J Biol Chem       Date:  2011-07-08       Impact factor: 5.157

2.  A ceramide analog inhibits cPLA(2) activity and consequent PGE(2) formation in LPS-stimulated macrophages.

Authors:  Meir Goldsmith; Ala Daka; Nadia F Lamour; Roi Mashiach; Yifat Glucksam; Michael M Meijler; Charles E Chalfant; Tsaffrir Zor
Journal:  Immunol Lett       Date:  2010-10-30       Impact factor: 3.685

3.  Altered miRNAs expression profiles and modulation of immune response genes and proteins during neonatal sepsis.

Authors:  Jiande Chen; Siyuan Jiang; Yun Cao; Yi Yang
Journal:  J Clin Immunol       Date:  2014-02-28       Impact factor: 8.317

Review 4.  Aspirin, cyclooxygenase inhibition and colorectal cancer.

Authors:  Carlos Sostres; Carla Jerusalen Gargallo; Angel Lanas
Journal:  World J Gastrointest Pharmacol Ther       Date:  2014-02-06

5.  Podocyte-specific knockout of cyclooxygenase 2 exacerbates diabetic kidney disease.

Authors:  Liming Wang; Yonggang Sha; Jingyi Bai; William Eisner; Matthew A Sparks; Anne F Buckley; Robert F Spurney
Journal:  Am J Physiol Renal Physiol       Date:  2017-05-10

6.  MSK1 and MSK2 inhibit lipopolysaccharide-induced prostaglandin production via an interleukin-10 feedback loop.

Authors:  Kirsty F MacKenzie; Mirjam W M Van Den Bosch; Shaista Naqvi; Suzanne E Elcombe; Victoria A McGuire; Alastair D Reith; Perry J Blackshear; Jonathan L E Dean; J Simon C Arthur
Journal:  Mol Cell Biol       Date:  2013-02-04       Impact factor: 4.272

7.  Integrin α3β1 controls mRNA splicing that determines Cox-2 mRNA stability in breast cancer cells.

Authors:  Sita Subbaram; Scott P Lyons; Kimberly B Svenson; Sean L Hammond; Lorena G McCabe; Sridar V Chittur; C Michael DiPersio
Journal:  J Cell Sci       Date:  2014-01-16       Impact factor: 5.285

8.  Methionine adenosyltransferase II-dependent histone H3K9 methylation at the COX-2 gene locus.

Authors:  Yohei Kera; Yasutake Katoh; Mineto Ohta; Mitsuyo Matsumoto; Teruko Takano-Yamamoto; Kazuhiko Igarashi
Journal:  J Biol Chem       Date:  2013-03-28       Impact factor: 5.157

9.  The role of translational regulation in ultraviolet C light-induced cyclooxygenase-2 expression.

Authors:  Csaba F László; Sherine Fayad; Oliver L Carpenter; Kimberly S George; Wei Lu; Abir Adel Abdel-Razak Saad; Shiyong Wu
Journal:  Life Sci       Date:  2009-05-05       Impact factor: 5.037

10.  PIM2 Induced COX-2 and MMP-9 expression in macrophages requires PI3K and Notch1 signaling.

Authors:  Kushagra Bansal; Nisha Kapoor; Yeddula Narayana; Germain Puzo; Martine Gilleron; Kithiganahalli Narayanaswamy Balaji
Journal:  PLoS One       Date:  2009-03-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.